Track topics on Twitter Track topics that are important to you
The post Genentech gets FDA approval for tumour-agnostic drug Rozlytrek appeared first on Pharmaceutical Technology.
Original Article: Genentech gets FDA approval for tumour-agnostic drug RozlytrekNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...